Developability of Biopharmaceuticals

-

By accounting for developability in candidate selection, drug developers have the potential to greatly minimize costly attrition and reduce development time significantly. However, this rapidly expanding area is not without its challenges, and key issues surrounding the early implementation of molecular assessments and rational engineering approaches need to be addressed.

Developability of Biopharmaceuticals has been designed to support drug developers in reducing the cost, risk and time of development. Our agenda focuses on the opportunities such as monitoring protein thermostability to ensure optimal conditions for bioprocess and exploring new high throughput screening methods to improve confidence in candidate selection.

Location:
Revere Hotel
USA


Organizer: Hanson Wade

4 Dec 2012

Upcoming Featured Events
1 Next 
Labcyte-University of Edinburgh Genomics Symposium 201628 Sep 2016
ASHG 201618 Oct 2016
PEGS Europe31 Oct 2016
Neuroscience 201612 Nov 2016
SLAS 20174 Feb 2017
Pittcon Conference and Expo 20175 Mar 2017


All Upcoming Events

Advertisement